- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Azacitidine (CC-486)
Total 2155 results
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, United Kingdom
-
CelgeneApproved for marketing
-
University of FlorenceRecruiting
-
CelgeneCompletedMyelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Acute Myelogenous Leukemia (AML)United States
-
Kirby InstituteCelgeneActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
CelgeneCompletedNasopharyngeal NeoplasmsCanada, United States, Taiwan, France, Spain, Greece, Italy, Singapore, Tunisia
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)WithdrawnAcute Myeloid LeukemiaUnited States
-
CelgeneActive, not recruitingNeoplasms | Hematologic Malignancies | Hematologic NeoplasmUnited Kingdom, United States
-
Translational Research in OncologyCelgeneTerminatedEpithelial Ovarian CancerUnited States
-
CelgeneCompletedMelanoma | Sarcoma | Neoplasms | Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Breast Cancer | Small Cell Lung Cancer | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Non-Small Cell Lung Cancer | Osteosarcoma | Glioblastoma Multiforme | Metastatic Breast... and other conditionsUnited States
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Bristol-Myers SquibbRecruiting
-
University of ChicagoCompletedFollicular LymphomaUnited States
-
CelgeneActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Italy, France, Germany, Greece, Spain
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Bristol-Myers SquibbRecruitingHepatic Insufficiency | NeoplasmsSpain, United States, Germany, Argentina, Colombia, Greece
-
John ReneauBristol-Myers SquibbRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
National Cancer Institute (NCI)WithdrawnHepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Extranodal NK-/T-cell Lymphoma, Nasal Type | Monomorphic Epiteliotrophic Intestinal T-cell LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedPancreatic CancerUnited States
-
University of BirminghamRecruitingAcute Myeloid Leukemia | MyelodysplasiaUnited Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Celgene CorporationCompletedColorectal CancerUnited States
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
-
University of Colorado, DenverBristol-Myers SquibbRecruiting
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Bristol-Myers SquibbRecruiting
-
CelgeneTerminatedBreast NeoplasmsSpain, United States, Belgium, Italy, France, Germany
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
CelgeneCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, France, Germany, Italy, Spain, United Kingdom
-
CelgeneCompletedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Tumor Virus Infections | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Transitional Cell | Carcinoma, Pancreatic DuctalSpain, United States, France, Netherlands
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Groupe Francophone des MyelodysplasiesBristol-Myers Squibb; AbbVieRecruitingUntreated Myelodysplastic SyndromeFrance
-
Ege UniversityCompletedEnd-stage Renal DiseaseTurkey
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Celgene CorporationCompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
University of OklahomaCelgene CorporationTerminatedPancreatic CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
CelgeneActive, not recruiting
-
CelgeneCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung CancerUnited States, Spain
-
Swiss Group for Clinical Cancer ResearchCompleted